Business Context and Reporting Period
This Form 6-K filing by SciSparc Ltd. (the "Company") covers the month of April 2024, specifically dated April 11, 2024. The filing announces a strategic transaction wherein the Company entered into an Agreement and Plan of Merger on April 10, 2024, with AutoMax Motors Ltd. ("AutoMax"), a leading vehicle importer in Israel. Upon consummation, AutoMax will become a wholly-owned subsidiary of SciSparc.
Key Financial Metrics and Transaction Terms
The filing details the financial structure of the proposed merger rather than historical operating results for the period.
- Ownership Structure: Post-merger, former AutoMax shareholders are expected to hold approximately 49.99% of the Company's outstanding ordinary shares on a fully diluted basis. Existing SciSparc shareholders and convertible security holders are expected to retain approximately 50.01%.
- Cash Consideration: At closing, the Company will deliver $4,250,000 to AutoMax via wire transfer for ongoing capital requirements and operational expenses, subject to deductions for any amounts AutoMax owes the Company under existing loan agreements.
- Board Composition: AutoMax will have the right to designate two or three members to the Company's Board of Directors, depending on the total board size, with at least one designee required to be an independent director.
- Shareholder Support: A Shareholder Support Agreement has been executed covering approximately 55.65% of AutoMax's outstanding shares, committing these holders to vote in favor of the merger.
Note: The filing text does not provide specific values for SciSparc's or AutoMax's current revenue, profit, cash flow, margins, or total debt levels.
Material Changes and Conditions
The primary material change is the execution of the Merger Agreement, which fundamentally alters the Company's business scope by adding a vehicle import business. The transaction is subject to several material conditions precedent, including:
- Approval by shareholders of both SciSparc and AutoMax.
- Court approval in accordance with the Israeli Companies Law.
- Effectiveness of a registration statement on Form F-4.
- Accuracy of representations and warranties and compliance with covenants.
- Existence of a minimum amount of Parent Net Cash held by the Company at the time of closing.
Outlook, Risks, and Contingencies
Management has issued forward-looking statements regarding the expected benefits and value creation of the merger. However, the filing highlights significant risks and contingencies that could prevent the transaction from closing or alter its terms:
- Transaction Risk: There is no assurance the merger will be completed due to potential failure to obtain shareholder or court approvals, or the inability to satisfy financing conditions.
- Operational Risk: Risks include the ability to manage operating expenses, integrate the businesses, and protect intellectual property.
- Market Risk: The market price of SciSparc's ordinary shares relative to the exchange ratio could impact the transaction's value.
- Liquidity Risk: The combined company may require additional capital to advance operations, which may not be available on favorable terms.
Investor Verification Checklist
- Verify the final Exchange Ratio and ownership percentages in the upcoming proxy statement.
- Confirm the satisfaction of the "Parent Net Cash" minimum requirement at the time of closing.
- Review the full text of the Merger Agreement (Exhibit 99.1) for specific termination provisions and indemnification details.
- Monitor the status of the Form F-4 registration statement and the Israeli Court approval process.
- Assess the financial health and debt obligations of AutoMax, as these will become liabilities of the combined entity.